2 results
Approved WMOCompleted
Primary Efficacy Objective (Blinded Treatment Period)• To demonstrate the efficacy of rilzabrutinib versus placebo in participants with refractory/relapsed ITP, based on the durability of platelet response during the last12 weeks of the 24-week…
Approved WMOCompleted
The aim of this first study is to compare the effect of manually performed jaw thrust with the effect of the boil and bite MAD (MyTAP) during DISE.